Literature DB >> 8726624

An analysis of breast cancer in Hungary: experience of the National Institute of Oncology, Budapest.

I Besznyák1, E Svastics.   

Abstract

Breast cancer is the most common type of cancer in women throughout the world (18%), with a yearly morbidity that is already over half a million. Its incidence in Hungary is increasing in each age group, and the mortality is strikingly high. This study was conducted to assess the effectiveness of breast-conserving surgery in comparison to more radical surgery on a large group of patients. During the 15 years between 1980 and 1994, a total of 6,358 patients with primary breast cancer underwent surgery at the National Institute of Oncology in Budapest, Hungary, as breast-conserving surgery in 2,026 patients (31.8%). Breast-conserving surgery is being performed in an ever-increasing number of patients, followed by adjuvant radiochemotherapy in premenopausal patients, or radiohormone therapy in menopausal patients. During follow-up, recurrence was found in only 5.9% of the patients who underwent breast-conserving treatment. Thus, according to our experience, breast conservation therapy for the management of breast cancer offers favourable results, provided that the preconditions to this treatment are adequately met.

Entities:  

Mesh:

Year:  1996        PMID: 8726624     DOI: 10.1007/BF00311609

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  37 in total

1.  [Interstitial radiotherapy of breast cancer. Preliminary report of a prospective study of 165 cases subjected to breast-conserving treatment].

Authors:  W Seitz; C Stanek; B Stadler; W Binder; R Jakesz; G Reiner
Journal:  Strahlenther Onkol       Date:  1990-10       Impact factor: 3.621

2.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Authors:  U Veronesi; B Salvadori; A Luini; A Banfi; R Zucali; M Del Vecchio; R Saccozzi; E Beretta; P Boracchi; G Farante
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

3.  The use of tissue expanders in immediate breast reconstruction following mastectomy for cancer.

Authors:  R H Schuster; S Rotter; W Boonn; G Efron
Journal:  Br J Plast Surg       Date:  1990-07

4.  Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

Authors:  M J Silverstein; E D Gierson; J R Waisman; G M Senofsky; W J Colburn; P Gamagami
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

5.  Tumorectomy and radiation therapy in early breast cancer: a report on 392 patients.

Authors:  J B Dubois; M Saumon-Reme; J Gary-Bobo; H Pourquier; H Pujol
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

6.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

Review 7.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

8.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

9.  A clinicopathological analysis of breast cancer in patients with a family history.

Authors:  T Fukutomi; Y Kobayashi; T Nanasawa; H Yamamoto; H Tsuda
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.

Authors:  D Sarrazin; M G Lê; R Arriagada; G Contesso; F Fontaine; M Spielmann; F Rochard; T Le Chevalier; J Lacour
Journal:  Radiother Oncol       Date:  1989-03       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.